Header Logo
Newsletter Podcast
Log In
← Back to all posts

Real Results with PRP, Staff Scripts That Work, and Events You’ll Love

May 06, 2025
Connect

Highlights

  • Today’s Research Article: PRP wins the long game — outperforms kinesiotaping for chronic heel pain with lasting relief and tissue regeneration.
  • Questions from the Field: Can you combine PRP and protein concentrate for osteoarthritis? Absolutely — and here’s why it works.
  • Let’s Get Down to Business: Your front desk is your secret salesforce — train them to sell PRP with empathy, not just prices.
  • Come Join Us: Get hands-on with regenerative medicine — meet us live at top events this May and July.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Regenerative efficacy of therapeutic quality platelet‐rich plasma injections versus phonophoresis with kinesiotaping for the treatment of chronic plantar fasciitis: A prospective randomized pilot study

Nitesh Gonnade, Archana Bajpayee, Abhay Elhence, Vaibhav Lokhande, Neeraj Mehta, Manish Mishra, Arunpreet Kaur

Read the full article here.

Summary:

This prospective randomized pilot study compared the long-term regenerative efficacy of autologous platelet-rich plasma (PRP) injections versus phonophoresis with kinesiotaping (KT) in patients with chronic plantar fasciitis unresponsive to conservative treatments. Out of 64 enrolled patients, 54 completed the 24-week follow-up. While KT provided better early pain relief at 2 weeks, PRP showed significantly greater improvements in pain (Numerical Rating Scale), foot function (Foot Function Index), and plantar fascia thickness at 12 and 24 weeks. The study used two ultrasound-guided PRP injections spaced two weeks apart, with a standardized preparation method ensuring high platelet concentration and minimal contamination.

The results support that PRP not only reduces symptoms but also promotes tissue regeneration in plantar fasciitis. Unlike KT, whose benefits were short-lived, PRP demonstrated sustained pain relief and structural improvement over six months, with no reported adverse effects. The study suggests that therapeutic-quality PRP injections can be a viable, cost-effective, and safer long-term option for managing chronic plantar fasciitis, especially in patients who have not responded to traditional therapies.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP’s edge on back pain, smarter marketing, and a live demo invite
Highlights Today’s Research Article: PRP outlasts steroids—stronger, safer, longer relief for back pain. Questions from the Field: From blood draw to injection: PRP takes just 20–25 minutes. Let’s Get Down to Business: Marketing isn’t sales—it’s how patients discover you. Come Join Us: See PRP in action—live demo & Q&A with Dr. Ariana DeMers.   If this newsletter was forwarded to you and you...
Stronger Shoulders, Smarter PRP, Better Marketing
Highlights Today’s Research Article: PRP beats PT in restoring shoulder function—lasting results without surgery. Questions from the Field: Not all PRP systems are equal—know your spin, know your outcomes. Let’s Get Down to Business: Doctors shouldn’t market alone—team up and thrive in today’s digital age. Come Join Us: Turn orthobiologic knowledge into profit at BOB Live—your Monday-r...
Grade IV OA? PRP Delivers – Plus, What to Do When Patients Don’t Respond
Highlights Today’s Research Article: Grade IV knee arthritis patients move better, hurt less, and skip the scalpel. Questions from the Field: When PRP results fall short, smart testing and re-dosing can turn non-responders into success stories. Let’s Get Down to Business: Connect, refer, and watch your practice grow. Come Join Us: BOB Live turns knowledge into profit   Turn what you...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.